Bildgebende Befunde bei Raumforderungen der kindlichen Orbita

Annie K. Joseph; Julie B. Guerin; Laurence J. Eckel; Lauren A. Dalvin; Gesina F. Keating; Greta B. Liebo; John C. Benson; Waleed Brinjikji; Nadia Laack; V. Michelle Silvera

doi:10.1055/a-2014-2220

Neuroradiologie Scan, Inhaltsverzeichnis

Neuroradiologie Scan 2023; 13(04): 271-292
DOI: 10.1055/a-2014-2220

CME-Fortbildung

Bildgebende Befunde bei Raumforderungen der kindlichen Orbita

Annie K. Joseph

,

Julie B. Guerin

,

Laurence J. Eckel

,

Lauren A. Dalvin

,

Gesina F. Keating

,

Greta B. Liebo

,

John C. Benson

,

Waleed Brinjikji

,

Nadia Laack

,

V. Michelle Silvera

Abstract

Durch die Anwendung eines kompartimentbasierten Ansatzes können Radiologen ein Spektrum von Raumforderungen und raumforderungsähnlichen Läsionen, die im kindlichen Augapfel auftreten, diagnostizieren. Im folgenden Beitrag werden die gemeinsamen und differenzierenden Merkmale dieser Läsionen in der Bildgebung beschrieben.

Schlüsselwörter

kindliche Orbita - Raumforderungen - intraokular - intrakonal - extrakonal

Volltext

Referenzen

Literatur
1 Kralik SF, Haider KM, Lobo RR. et al. Orbital infantile hemangioma and rhabdomyosarcoma in children: differentiation using diffusion-weighted magnetic resonance imaging. J AAPOS 2018; 22: 27-31
2 Jaju A, Rychlik K, Ryan ME. MRI of pediatric orbital masses: role of quantitative diffusion-weighted imaging in differentiating benign from malignant lesions. Clin Neuroradiol 2020; 30: 615-624
3 Sepahdari AR, Politi LS, Aakalu VK. et al. Diffusion-weighted imaging of orbital masses: multi-institutional data support a 2-ADC threshold model to categorize lesions as benign, malignant, or indeterminate. AJNR Am J Neuroradiol 2014; 35: 170-175
4 Teixeira SR, Martinez-Rios C, Hu L. et al. Clinical applications of pediatric positron emission tomography-magnetic resonance imaging. Semin Roentgenol 2014; 49: 353-366
5 Silvera VM, Guerin JB, Brinjikji W. et al. Retinoblastoma: What the neuroradiologist needs to know. AJNR Am J Neuroradiol 2021; 42: 618-626
6 Galluzzi P, Hadjistilianou T, Cerase A. et al. Is CT still useful in the study protocol of retinoblastoma?. AJNR Am J Neuroradiol 2009; 30: 1760-1765
7 de Graaf P, Barkhof F, Moll AC. et al. Retinoblastoma: MR imaging parameters in detection of tumor extent. Radiology 2005; 235: 197-207
8 Shastry BS. Persistent hyperplastic primary vitreous: congenital malformation of the eye. Clin Exp Ophthalmol 2009; 37: 884-890
9 Esmer AC, Sivrikoz TS, Gulec EY. et al. Prenatal diagnosis of persistent hyperplastic primary vitreous: report of 2 cases and review of the literature. J Ultrasound Med 2016; 35: 2285-2291
10 Dalvin LA, Udyaver S, Lim LS. et al. Coats disease: clinical features and outcomes by age category in 351 cases. J Pediatr Ophthalmol Strabismus 2019; 56: 288-296
11 Sen M, Shields CL, Honavar SG. et al. Coats disease: an overview of classification, management and outcomes. Indian J Ophthalmol 2019; 67: 763-771
12 Jansen RW, de Bloeme CM, Brisse HJ. et al. MR imaging features to differentiate retinoblastoma from Coatsʼ disease and persistent fetal vasculature. Cancers (Basel) 2020; 12: E3592
13 Smoker WR, Gentry LR, Yee NK. et al. Vascular lesions of the orbit: more than meets the eye. RadioGraphics 2008; 28: 185-204; quiz 325
14 Nassiri N, Rootman J, Rootman DB. et al. Orbital lymphaticovenous malformations: current and future treatments. Surv Ophthalmol 2015; 60: 383-405
15 Bisdorff A, Mulliken JB, Carrico J. et al. Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. AJNR Am J Neuroradiol 2007; 28: 335-341
16 International Society for the Study of Vascular Anomalies. ISSVA classification of vascular anomalies, 2018. Zugriff am 21. März 2023 unter: https://www.issva.org/classification
17 Lally SE. Update on orbital lymphatic malformations. Curr Opin Ophthalmol 2016; 27: 413-415
18 Barnacle AM, Theodorou M, Maling SJ. et al. Sclerotherapy treatment of orbital lymphatic malformations: a large single-centre experience. Br J Ophthalmol 2016; 100: 204-208
19 Yong KL, Beckman TJ, Cranstoun M. et al. Orbital schwannoma-management and clinical outcomes. Ophthal Plast Reconstr Surg 2020; 36: 590-595
20 Coy S, Rashid R, Stemmer-Rachamimov A. et al. An update on the CNS manifestations of neurofibromatosis type 2. Acta Neuropathol (Berl. 2020; 139: 643-665 [published correction in Acta Neuropathol 2020; 139 (4): 667]
21 Wang Y, Xiao LH. Orbital schwannomas: findings from magnetic resonance imaging in 62 cases. Eye (Lond) 2008; 22: 1034-1039
22 Parker RT, Ovens CA, Fraser CL. et al. Optic nerve sheath meningiomas: prevalence, impact, and management strategies. Eye Brain 2018; 10: 85-99
23 Li P, Wang Z, Zhou Q. et al. A retrospective analysis of vision-impairing tumors among 467 patients with neurofibromatosis type 2. World Neurosurg 2017; 97: 557-564
24 Liu D, Xu D, Zhang Z. et al. Long-term results of gamma knife surgery for optic nerve sheath meningioma. J Neurosurg 2010; 113 (Suppl. 01) 28-33
25 Fried I, Tabori U, Tihan T. et al. Optic pathway gliomas: a review. CNS Oncol 2013; 2: 143-159
26 Louis DN, Perry A, Reifenberger G. et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl.). 2016; 131: 803-820
27 Ding C, Tihan T. Recent progress in the pathology and genetics of pilocytic and pilomyxoid astrocytomas. Balkan Med J 2019; 36: 3-11
28 Aihara Y, Chiba K, Eguchi S. et al. Pediatric optic pathway/hypothalamic glioma. Neurol Med Chir (Tokyo) 2018; 58: 1-9
29 de Blank PMK, Fisher MJ, Liu GT. et al. Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision. J Neuroophthalmol 2017; 37 (Suppl. 01) S23-S32
30 Fangusaro J, Witt O, Hernáiz Driever P. et al. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 2020; 21: e305-e316
31 Nicolin G, Parkin P, Mabbott D. et al. Natural history and outcome of optic pathway gliomas in children. Pediatr Blood Cancer 2009; 53: 1231-1237
32 Banerjee A, Jakacki RI, Onar-Thomas A. et al. A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. Neuro Oncol 2017; 19: 1135-1144
33 Menapace D, Mitkov M, Towbin R. et al. The changing face of complicated infantile hemangioma treatment. Pediatr Radiol 2016; 46: 1494-1506
34 Darrow DH, Greene AK, Mancini AJ. et al. Section on Dermatology, Section on Otolaryngology–Head and Neck Surgery, and Section on Plastic Surgery. Diagnosis and management of infantile hemangioma. Pediatrics 2015; 136: e1060-e1104
35 Mulliken JBMD, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412-422
36 Harter N, Mancini AJ. Diagnosis and management of infantile hemangiomas in the neonate. Pediatr Clin North Am 2019; 66: 437-459
37 Krowchuk DP, Frieden IJ, Mancini AJ. et al. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics 2019; 143: e20183475
38 Mamlouk MD, Hess CP. Arterial spin-labeled perfusion for vascular anomalies in the pediatric head and neck. Clin Imaging 2016; 40: 1040-1046
39 Hatayama K, Watanabe H, Ahmed AR. et al. Evaluation of hemangioma by positron emission tomography: role in a multimodality approach. J Comput Assist Tomogr 2003; 27: 70-77
40 Kim JS, Chandler A, Borzykowski R. et al. Maximizing time-resolved MRA for differentiation of hemangiomas, vascular malformations and vascularized tumors. Pediatr Radiol 2012; 42: 775-784
41 Boutroux H, Cellier C, Mosseri V. et al. Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy. J Pediatr Hematol Oncol 2014; 36: 605-612
42 Conneely MF, Mafee MF. Orbital rhabdomyosarcoma and simulating lesions. Neuroimaging Clin N Am 2005; 15: 121-136
43 Karcioglu ZA, Hadjistilianou D, Rozans M. et al. Orbital rhabdomyosarcoma. Cancer Contr 2004; 11: 328-333
44 Spindle J, Tang SXMD, Davies B. et al. Pediatric idiopathic orbital inflammation: clinical features of 30 cases. Ophthal Plast Reconstr Surg 2016; 32: 270-274
45 Belanger C, Zhang KS, Reddy AK. et al. Inflammatory disorders of the orbit in childhood: a case series. Am J Ophthalmol 2010; 150: 460-463
46 Karim F, Loeffen J, Bramer W. et al. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online J 2016; 14: 18
47 Moustafa GA, Topham AK, Aronow ME. et al. Paediatric ocular adnexal lymphoma: a population-based analysis. BMJ Open Ophthalmol 2020; 5: e000483
48 Ren J, Yuan Y, Wu Y. et al. Differentiation of orbital lymphoma and idiopathic orbital inflammatory pseudotumor: combined diagnostic value of conventional MRI and histogram analysis of ADC maps. BMC Med Imaging 2018; 18: 6
49 Eissa L, Abdel Razek AAK, Helmy E. Arterial spin labeling and diffusion-weighted MR imaging: utility in differentiating idiopathic orbital inflammatory pseudotumor from orbital lymphoma. Clin Imaging 2021; 71: 63-68
50 AlSemari MA, Perrotta M, Russo C. et al. Orbital myeloid sarcoma (chloroma): report of 2 cases and literature review. Am J Ophthalmol Case Rep 2020; 19: 100806
51 DʼAmbrosio N, Lyo J, Young R. et al. Common and unusual craniofacial manifestations of metastatic neuroblastoma. Neuroradiology 2010; 52: 549-553
52 Rubin PAD, Remulla HD. Orbital venous anomalies demonstrated by spiral computed tomography. Ophthalmology 1997; 104: 1463-1470
53 Kalin-Hajdu E, Colby JB, Idowu O. et al. Diagnosing distensible venous malformations of the orbit with diffusion-weighted magnetic resonance imaging. Am J Ophthalmol 2018; 189: 146-154
54 Avery RA, Katowitz JA, Fisher MJ. et al. Orbital/periorbital plexiform neurofibromas in children with neurofibromatosis type 1: multidisciplinary recommendations for care. Ophthalmology 2017; 124: 123-132
55 Milburn JM, Gimenez Jr CR, Dutweiler E. Clinical images: imaging manifestations of orbital neurofibromatosis type 1. Ochsner J 2016; 16: 431-434
56 Wy S, Kim N. Orbital malignant peripheral nerve sheath tumor arising from neurofibroma. Korean J Ophthalmol 2019; 33: 301-302
57 Gao Y, Moonis G, Cunnane ME. et al. Lacrimal gland masses. AJR Am J Roentgenol 2013; 201: W371-W381
58 Bryant JR, Mantilla-Rivas E, Manrique M. et al. A rare pediatric case of lacrimal gland pleomorphic adenoma. Plast Reconstr Surg Glob Open 2019; 7: e2435
59 Chandrasekhar J, Farr DR, Whear NM. Pleomorphic adenoma of the lacrimal gland: case report. Br J Oral Maxillofac Surg 2001; 39: 390-393
60 Lai T, Prabhakaran VC, Malhotra R. et al. Pleomorphic adenoma of the lacrimal gland: Is there a role for biopsy?. Eye (Lond) 2009; 23: 2-6
61 Chung EM, Smirniotopoulos JG, Specht CS. et al. From the archives of the AFIP: pediatric orbit tumors and tumorlike lesions: nonosseous lesions of the extraocular orbit. RadioGraphics 2007; 27: 1777-1799
62 Cavazza S, Laffi GL, Lodi L. et al. Orbital dermoid cyst of childhood: clinical pathologic findings, classification and management. Int Ophthalmol 2011; 31: 93-97
63 Pushker N, Meel R, Kumar A. et al. Orbital and periorbital dermoid/epidermoid cyst: a series of 280 cases and a brief review. Can J Ophthalmol 2020; 55: 167-171
64 Shields JA, Shields CL. Orbital cysts of childhood: classification, clinical features, and management. Surv Ophthalmol 2004; 49: 281-299
65 Dave TV, Gupta Rathi S, Kaliki S. et al. Orbital and periorbital dermoid cysts: comparison of clinical features and management outcomes in children and adults. Eur J Ophthalmol 2021; 31: 2631-2638
66 Ahmed RA, Eltanamly RM. Orbital epidermoid cysts: a diagnosis to consider. J Ophthalmol 2014; 2014: 508425
67 Rao AA, Naheedy JH, Chen JYY. et al. A clinical update and radiologic review of pediatric orbital and ocular tumors. J Oncol 2013; 2013: 975908
68 Kroiss A, Putzer D, Uprimny C. et al. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification. Eur J Nucl Med Mol Imaging 2012; 39: 543
69 Swift CC, Eklund MJ, Kraveka JM. et al. Updates in diagnosis, management, and treatment of neuroblastoma. RadioGraphics 2018; 38: 566-580
70 Abla O, Rollins B, Ladisch S. Langerhans cell histiocytosis: progress and controversies. Br J Haematol 2019; 187: 559-562
71 Lakatos K, Sterlich K, Pötschger U. et al. Langerhans cell histiocytosis of the orbit: spectrum of clinical and imaging findings. J Pediatr 2021; 230: 174.e1-181.e1
72 Wu C, Li K, Hei Y. et al. MR imaging features of orbital Langerhans cell histiocytosis. BMC Ophthalmol 2019; 19: 263
73 Kilborn TN, Teh J, Goodman TR. Paediatric manifestations of Langerhans cell histiocytosis: a review of the clinical and radiological findings. Clin Radiol 2003; 58: 269-278
74 Esmaili N, Harris GJMD. Langerhans cell histiocytosis of the orbit: spectrum of disease and risk of central nervous system sequelae in unifocal cases. Ophthal Plast Reconstr Surg 2016; 32: 28-34